Literature DB >> 18177393

Help-seeking behaviour in patients with lymphoma.

D A Howell1, A G Smith, E Roman.   

Abstract

Reducing cancer mortality is a priority for the UK Government and emphasis has been placed on introducing targets to ensure prompt diagnosis. Help seeking is the first step on the pathway to diagnosis and should occur promptly; however, patients with lymphoma take longer to seek help for symptoms than those with many other cancers. Despite this, the help seeking behaviour of these patients has not been investigated. This qualitative study examined the beliefs and actions about help seeking among 32 patients, aged 65 and over and newly diagnosed with lymphoma in West Yorkshire during 2000. Patients reported an extremely wide range of symptoms which were not always interpreted as serious or potentially caused by cancer. This, in association with a clear lack of knowledge about lymphoma, often led to help seeking being deferred. The range and characteristics of symptoms can largely be explained in terms of variations in the type, site and size of the lymphoma. The UK Government targets focus on the time after help seeking, yet for lymphoma it is also crucial to reduce the time taken to seek help. More education about the potential symptoms of this disease is needed among the general public.

Entities:  

Mesh:

Year:  2008        PMID: 18177393     DOI: 10.1111/j.1365-2354.2007.00897.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  12 in total

1.  Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case-control study using electronic records.

Authors:  Elizabeth A Shephard; Richard D Neal; Peter W Rose; Fiona M Walter; William T Hamilton
Journal:  Br J Gen Pract       Date:  2015-05       Impact factor: 5.386

2.  Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.

Authors:  A Smith; D Howell; R Patmore; A Jack; E Roman
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

3.  The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial.

Authors:  Sibilah Breen; David Ritchie; Penelope Schofield; Ya-Seng Hsueh; Karla Gough; Nick Santamaria; Rose Kamateros; Roma Maguire; Nora Kearney; Sanchia Aranda
Journal:  Trials       Date:  2015-10-19       Impact factor: 2.279

4.  Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.

Authors:  Eleanor Kane; Debra Howell; Alexandra Smith; Simon Crouch; Cathy Burton; Eve Roman; Russell Patmore
Journal:  Eur J Cancer       Date:  2017-04-13       Impact factor: 9.162

5.  Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain.

Authors:  Xavier Bosch; Carmen Sanclemente-Ansó; Ona Escoda; Esther Monclús; Jonathan Franco-Vanegas; Pedro Moreno; Mar Guerra-García; Neus Guasch; Alfons López-Soto
Journal:  BMC Cancer       Date:  2018-03-12       Impact factor: 4.430

6.  Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients.

Authors:  Andrea Kühnl; David Cunningham; Margaret Hutka; Clare Peckitt; Hamoun Rozati; Federica Morano; Irene Chong; Angela Gillbanks; Andrew Wotherspoon; Michelle Harris; Tracey Murray; Ian Chau
Journal:  BMC Hematol       Date:  2018-08-14

7.  Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a case-control study using electronic records.

Authors:  Elizabeth A Shephard; Richard D Neal; Peter W Rose; Fiona M Walter; William T Hamilton
Journal:  Br J Gen Pract       Date:  2015-05       Impact factor: 5.386

8.  Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.

Authors:  Debra A Howell; Alexandra G Smith; Andrew Jack; Russell Patmore; Una Macleod; Emma Mironska; Eve Roman
Journal:  BMC Hematol       Date:  2013-10-31

9.  Patient delay in cancer diagnosis: what do we really mean and can we be more specific?

Authors:  Christina Mary Dobson; Andrew James Russell; Greg Paul Rubin
Journal:  BMC Health Serv Res       Date:  2014-09-12       Impact factor: 2.655

10.  Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.

Authors:  Debra A Howell; Fiona Warburton; Amanda-Jane Ramirez; Eve Roman; Alexandra G Smith; Lindsay J L Forbes
Journal:  Br J Cancer       Date:  2015-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.